Chest wall abnormalities in Swiss childhood cancer survivors

Swiss Childhood Cancer Survivor Study

The Swiss Childhood Cancer Survivor Study (SCCSS) is a population-based, long-term follow-up study of patients registered in the Swiss Childhood Cancer Registry (SCCR, www.childhoodcancerregistry.ch). Participants had been diagnosed with leukemia, lymphoma, CNS tumors, malignant solid tumors, or Langerhans cell histiocytosis since 1976 and before the age of 21 years. Participants, who had survived ≥5 years since initial cancer diagnosis and were alive at the time of the study,^13,14 received a questionnaire between 2007 and 2013. Nonresponders received a second copy of the questionnaire four to six weeks later. If they again did not answer, we contacted them by phone. In total 2,382 survivors replied (Supplementary figure S1). Detailed methods of the SCCSS have been published.^12-14

Outcome: Chest wall abnormalities

The SCCSS questionnaire, like the North Amercian¹⁵ and British¹⁶ Childhood Cancer Survivor Studies, includes one question on chest wall abnormalities in the section on pulmonary health: “Have you ever been told by a doctor that you have or have had changes on your thorax and/or ribs?” and possible answers included ever in live (yes/no), since when (year), currently (yes/no) (Supplementary figure S2).

Validation of outcome by telephone interview

In a nested follow-up study, we sent a letter to all survivors who had reported a chest wall abnormality in the questionnaire to invite them to take part in a telephone interview. All those were at least 18 years old, still alive, had consented to participation in further studies and had a valid telephone number. Survivors were contacted by telephone between July 2017 and September 2017 by one investigator (CL) (Supplementary figure S1). The purpose of the structured interview was to determine the medical problems underlying the chest wall abnormalities. We sought information on 1) deformations of the chest wall that included asymmetric chest wall, pectus excavatum, pectus carinatum, completely or partially missing ribs, deformation of the breast, muscular abnormalities or other deformations of the chest wall or ribs, 2) deformations of the spine including scoliosis, hyperkyphosis, hyperlordosis or other deformations of the spine, and 3) scars on the chest wall. We also asked about the impact of chest wall abnormalities on daily life which could include general complaints as well as cosmetic problems, respiration problems, flexibility impairments, pain because of the chest wall abnormalities, and impairment in activities of daily living. We also asked whether medical attention – consultation with a physician, diagnostic investigations, operations and physiotherapy – had been sought. The questionnaire used for the interview is available on request.

The Ethics Committee of the Canton of Bern approved the SCCR and the SCCSS (KEK-BE: 166/2014), and the Swiss Childhood Cancer Survivor Study is registered at ClinicalTrials.gov (identifier: NCT03297034).

Covariates: Demographic and cancer-related characteristics

We obtained cancer characteristics from the SCCR including age at diagnosis, year of diagnosis, cancer diagnosis according to the International Classification of Childhood Cancer, 3rd edition ¹⁷, and details on radiotherapy, surgery, and chemotherapy. We combined total body irradiation, mantle field radiation, and radiation to the thorax, lungs, mediastinum, or thoracic spine to thoracic radiotherapy (yes/no). Surgery to the chest (yes/no) included the clavicles, scapulae and ribs, tumor excision from soft tissue on thorax, thoracic muscles, thoracic spine, and tumor or lymph node biopsies on the chest wall.

Statistical analysis

We reported prevalence of chest wall abnormalities overall and stratified by sex, age at cancer diagnosis (0–5, 6–10, 11–15, 16–20), years of diagnosis (1976–1990, 1991–2005), cancer diagnosis (leukemia, lymphoma, CNS tumor, other tumors) and cancer treatment (thoracic radiotherapy (yes, no), surgery to the chest (yes, no), any chemotherapy (yes, no)). We identified demographic and cancer-related risk factors for chest wall abnormalities using univariable and multivariable logistic regression. All analyses were done in Stata (Version 14; Stata Corporation, Austin, TX).

Systematic literature review

We conducted a literature review searching for relevant articles in the two bibliographic databases PubMed and Embase Ovid, last updated December 31th 2019. Both databases were searched using thesaurus terms (MeSH, Emtree) and textwords. We applied restrictions to language and searched studies on humans only, and excluded from the search conference abstracts, letters to the editor and editorials. To retrieve further relevant publications, we checked the reference lists of studies included and added Google scholar for a full-text search. An information specialist from the University Library of Bern was consulted to set up the search strategies in order to ensure optimal data acquisition.

The search results were screened in two steps by two independent reviewers (RK, CL) and assessed according to relevance and eligibility criteria (PRISMA flow diagram). Additional articles were searched by screening the reference list of suitable systematic reviews found in the two databases. For details on search strategies and search platforms, see Supplementary Text and Supplementary figure S3.

Prevalence and risk factors of chest wall abnormalities

Among 2,382 survivors who participated in the SCCSS, 2% (48/2,382) reported a chest wall abnormality (95% confidence interval [95%CI] 1.5–2.7). Male survivors were more often affected (2.5%, 95%CI 1.8–3.5) than females (1.4%, 95%CI 0.8–2.3) (table 1). Median age at study was 31 years (interquartile range [IQR] 25 – 38) and survivors who were older at cancer diagnosis (16-20 years, 4.2%, 95%CI 2.2 – 7.9) had a higher prevalence of chest wall abnormalities compared to those who were younger. Prevalence did not change over time, being 2% and 2.1% in the periods of 1976–1990 and 1991–2005. When comparing underlying diagnoses, chest wall abnormalities were most frequently reported by survivors of lymphoma (3.7%, 95%CI 2.3–6.0) and CNS tumors (3.8%, 95%CI 2.2–6.4), but rarely by participants treated for leukemia (0.6%, 95%CI 0.2–1.5). Nearly 8% of survivors treated with surgery to the chest and 6% treated with thoracic radiotherapy reported a chest wall abnormality.

In a multivariable regression, the following factors remained independently associated with chest wall abnormalities: male sex (odds ratio [OR] 1.8, 95%CI 1.0–3.3), older age at cancer diagnosis (OR 2.5, 95%CI 1.0–6.1), lymphoma (OR 3.8, 95%CI 1.2–11.4), CNS tumor (OR 9.5, 95%CI 3.0–30.1), thoracic radiotherapy (OR 2.0, 95%CI 1.0–4.2), surgery to the chest (OR 4.5, 95%CI 1.8–11.5), and chemotherapy (OR 2.9, 95%CI 1.0–8.1) (table 2).

Telephone interviews

Among the 48 survivors who reported chest wall abnormalities, 25 survivors were eligible for being interviewed and 20 participated (80%), 18 confirmed to have a chest wall abnormality (Table 3). When asked in more detail, 85% (17/20) described thoracic wall deformities, 60% (12/20) a deformation of the spine, and 70% (14/20) scars on the chest wall. Most survivors (80%;16/20) reported multiple problems (Figure 1 and Table 3). Thoracic wall deformities included pectus excavatum, pectus carinatum and unspecified thoracic asymmetries, missing or deformed ribs, and deformation of the breasts. Deformation of the spine included scoliosis, hyper kyphosis, and hyper lordosis.

• Download figure
• Open in new tab

Figure 1.

Proportional Venn-diagram showing reported types and overlap of chest wall abnormalities in childhood cancer survivors in the telephone interview.

We also asked survivors whether the chest wall abnormalities affected their daily life and if they had sought medical attention. Among the 20 survivors interviewed, 13 survivors said that the chest wall abnormality affected respiration, flexibility, and activities of daily life, caused cosmetic problems, or pain (table 3). Fifteen survivors had sought medical attention. Fourteen consulted a doctor (10 visited one specialist only and four visited multiple specialists). Specialists included general practitioners, pediatric oncologists, orthopedists, chiropractors, surgeons, sport physicians or rheumatologists. Nine survivors underwent diagnostic testing, six had a chest x-ray only and three a chest x-rays and lung function tests. One survivor had needed an operation, and six had been treated by physiotherapists (table 3).

Literature Review

Of 2,167 potentially relevant articles identified, we excluded 1,935 articles after screening of title and abstracts, leaving 244 articles for full text screening. Of those, we excluded a further 232 articles that did not meet inclusion criteria (Supplementary figure S3). We summarized the remaining in table 4. Among these, only two investigated in an unselected cohort of survivors with regard to cancer diagnosis and treatment.^11,12 Both used postal questionnaires (the Swiss and North American Childhood Cancer Survivor Studies) and found a prevalence of chest wall abnormalities of 2.0%¹² and 1.3%¹¹. Six studies focused on survivors of selected cancer diagnoses; one on chest wall sarcoma,¹ one on CNS tumours,¹⁰ two on neuroblastoma,^2,9 and two on Wilms tumour.^3,4 Four studies focused on specific cancer treatments only: one on operations of solid tumours⁵ and three on irradiation including at least parts of the thorax^6-8.

Scoliosis was reported mainly in survivors of neuroblastoma and Wilms tumor, and after radiotherapy of the spine^2-4,8,9. Breast asymmetries with severe cosmetic deformities were described in 35% of female survivors after radiation to the spine⁶. Breast underdevelopment was reported in 11% of survivors who had undergone chest radiation.⁵ Scars resulting in psychological problems was described in 80% of survivors of solid malignancies after surgery.⁵ Asymmetries of the ribs, scapula and thorax were described after neuroblastoma, Wilms tumor, and chest and abdominal radiotherapy.^2,5,7 Studies that focused on selected outcomes or treatments reported a higher prevalence of chest wall abnormalities than studies based on unselected survivor cohorts (table 4).